secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001636422-24-000148
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 3.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q3 revenue $76.4M, Adj. EBITDA $7.3M; acquires Intraprise for $43M
--------------------------------------------------------------------------------

- Q3 2024 total revenue $76.4M, net loss $14.7M, Adjusted EBITDA $7.3M (above guidance midpoint of $6-8M).
- FY 2024 Adjusted EBITDA guidance raised to $25-27M (from $24-26M); revenue guidance unchanged at $305-311M.
- Acquired Intraprise Health for $43M (cash and ~2.2M shares at $8.18); expected close by end of 2024, immaterial near-term financial impact.
- Appointed Dr. Jill Hoggard Green to board effective Dec 1, 2024; she is former CEO of The Queens Health System, a client.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000148/0001636422-24-000148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000148/hcat-20241102.htm
  HTML page:      https://secwatch.observer/filing/0001636422-24-000148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer